- CA$1.25bn
- CA$1.19bn
- CA$369.31m
- 87
- 63
- 93
- 95
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 296 | 157 | 207 | 335 | 369 |
Cost of Revenue | |||||
Gross Profit | 135 | 44.4 | 93.3 | 192 | 204 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 218 | 145 | 162 | 211 | 235 |
Operating Profit | 77.9 | 11.5 | 44.6 | 124 | 134 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 74 | 10 | 43.7 | 139 | 130 |
Provision for Income Taxes | |||||
Net Income After Taxes | 53.8 | 5.13 | 31.9 | 106 | 95.8 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 54.1 | 6.57 | 33.8 | 108 | 97.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 54.1 | 6.57 | 33.8 | 108 | 97.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.634 | -0 | 0.336 | 1.3 | 1.21 |
Dividends per Share |